Skip to content
GLP-1 Savers
Menu
Ranked #272 · Watch List

Invyncible review

Invyncible is a Florida-based telehealth brand operated by Nationwide Telemedicine, LLC, publishing every compounded semaglutide and tirzepatide program price on its open catalog across 46 states plus DC.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $149/mo

Save ~86% vs brand-name

From $149/mo (0.45 mg dose, compounded with glycine + B12)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. Every figure is published on the open catalog with no signup, but each one is shown against a permanently struck-through higher price and the category page invites you to call for more off — a discount that never expires is a price, not a saving. The oral route is priced separately at $255.50 for the semaglutide + B12 capsule program. The cheapest injectable program publishes no supply duration, so its monthly figure is a conservative reading rather than a rate Invyncible states.

How much does Invyncible cost?

The price Invyncible publishes is From $149/mo (0.45 mg dose, compounded with glycine + B12). Tirzepatide is listed at From $180/mo (2.5 mg weekly, 4-week program, compounded). We flag this one to watch: confirm the ongoing rate with Invyncible before you count on it, because a low first month can step up afterward. That works out about 86% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $149/mo (0.45 mg dose, compounded with glycine + B12)
Tirzepatide
From $180/mo (2.5 mg weekly, 4-week program, compounded)
Coverage
46 states plus DC
Brand-name
Yes

The Value Score card

Invyncible scored on our six published factors. See the methodology.

Lowest Real Price73/100
No Teaser-Rate Bait30/100
Nationwide Availability72/100
Both Molecules92/100
Easy Cancellation95/100
Reputation60/100

Why it's a deal

  • Prices every dose program on the open catalog — no account, no intake, no quiz — and each product page re-prices as you change dose
  • Names all six compounding pharmacies with street addresses and phone numbers, names the specific pharmacy on some product pages, and lets the patient choose which one fills the prescription
  • Stocks FDA-approved brand Wegovy ($1,750) and Zepbound ($1,540) alongside compounded, and an oral semaglutide capsule program, each labeled as such on the catalog
  • Refills are requested rather than auto-billed, and the card is only charged if a provider approves the prescription
  • Names its operating company — Nationwide Telemedicine, LLC — states that the affiliated medical practices are independently owned, and publishes informed-consent, privacy, shipping and terms documents separately

Read the fine print

  • Every price is shown against a permanent struck-through list figure, which is anchoring rather than a saving
  • The entry figure is the smallest vial: plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
  • No 503A or 503B designation is given for any of the six named pharmacies
  • The glycine + B12 program publishes no supply duration, so its figure cannot be converted to a monthly rate from the page
  • Compounded semaglutide is unavailable in six more states than the company's 46-state footprint, and tirzepatide in seven

The bottom line

Best for: Someone who wants to read the price of every dose program, and the name of the pharmacy filling it, before handing over any details. Invyncible is a Florida-based telehealth brand operated by Nationwide Telemedicine, LLC, publishing every compounded semaglutide and tirzepatide program price on its open catalog across 46 states plus DC.

Ranked #272 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Invyncible, out of 426 others we track.

Shopping Invyncible against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Invyncible, and every program that undercuts or outscores it — starting with ElixaMD, the closest match on score — is ranked on the Invyncible alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Invyncible's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Invyncible's site. Not medical advice; see our disclosure.

Where Invyncible ranks

See every program ranked by price →

← Back to all deals